Calmare Therapeutics Incorporated (OTCMKTS:CTTC – Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Calmare Therapeutics shares last traded at $0.00, with a volume of 0 shares trading hands.
Calmare Therapeutics Price Performance
Calmare Therapeutics Company Profile
Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain.
Featured Articles
- Five stocks we like better than Calmare Therapeutics
- How Investors Can Find the Best Cheap Dividend Stocks
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What is the Hang Seng index?
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Calmare Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calmare Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
